Gentherm Reports 2021 Third Quarter Results
Gentherm (NASDAQ:THRM) reported third-quarter financial results for 2021, with product revenues of $243.4 million, down 6.2% from $259.5 million a year ago. Adjusted earnings per share decreased to $0.51 from $0.91. Despite these declines, the company secured $260 million in new automotive awards, with 40% allocated to electric vehicles. Gross margin fell to 28.5% due to supply chain issues, while R&D expenses increased 13.9%. Gentherm updated its full-year guidance for product revenues to between $1.02 billion and $1.05 billion.
- Secured $260 million in new automotive business awards.
- 40% of new awards are for electric vehicles.
- Increased cash flow from operations by over 40% year-over-year.
- Product revenues decreased by 6.2% year-over-year.
- GAAP diluted EPS dropped to $0.47, down from $0.73.
- Gross margin decreased to 28.5% from 31.8%, impacted by supply chain disruptions.
Automotive Revenue Continued to Significantly Outperform Light Vehicle Production
Secured
Updates 2021 Guidance
NORTHVILLE, Mich., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management technologies, today announced its financial results for the third quarter ended September 30, 2021.
Third Quarter Highlights
- Product revenues of
$243.4 million decreased6.2% from$259.5 million in the 2020 third quarter - Excluding the impact of foreign currency translation, product revenues decreased
7.3% year over year - GAAP diluted earnings per share was
$0.47 as compared to$0.73 in the prior-year period - Adjusted earnings per share (see table herein) was
$0.51 as compared to$0.91 in the prior-year period - Secured automotive new business awards totaling
$260 million
Phil Eyler, the Company's President and CEO, said “I am proud of the team for their strong execution in the third quarter, despite the unprecedented global supply chain disruption and production volatility. In Automotive, we continued to significantly outperform light vehicle production in the key markets we serve and secured
“While supply disruptions and production volatilities will remain challenging in the foreseeable future, our relentless focus on operational execution, innovation and cash flow generation position us well to continue to drive shareholder value over the long term,” continued Eyler.
2021 Third Quarter Financial Review
Product revenues of
Automotive revenues decreased
Gentherm Medical revenue increased
See the “Revenue by Product Category” table included below for additional detail.
The gross margin rate decreased to
Net research and development expenses of
Selling, general and administrative expenses of
Restructuring expenses for the third quarter of 2021 were
As described more fully in the table included below, “Reconciliation of Net Income to Adjusted EBITDA,” the Company recorded Adjusted EBITDA of
Income tax expense in the 2021 third quarter was
GAAP diluted earnings per share for the third quarter of 2021 was
Guidance
The Company is updating its full-year 2021 guidance that was last provided on September 14, 2021:
- Product revenues between
$1.02 billion and$1.05 billion , based on the current forecast of customer orders, production outlook, supply chain constraints and current foreign exchange rates - Adjusted EBITDA between
14% and15% of product revenues - Full-year effective tax rate between
20% and22% - Capital expenditures between
$40 million and$50 million
Conference Call
As previously announced, Gentherm will conduct a conference call today at 8:00 am Eastern Time to review these results. The dial-in number for the call is 1-877-407-4018 (callers in the U.S.) or +1-201-689-8471 (callers outside this U.S.). The passcode for the live call is 13724009.
A live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor section of Gentherm's website at www.gentherm.com.
A telephonic replay will be available approximately two hours after the call until 11:59 pm Eastern Time on November 11, 2021. The replay can be accessed by dialing 1-844-512-2921 (callers in the U.S.), or +1-412-317-6671 (callers outside the U.S.). The passcode for the replay is 13724009.
Investor Relations Contact
Yijing Brentano
investors@gentherm.com
(248) 308-1702
Media Contact
Melissa Fischer
media@gentherm.com
248.289.9702
About Gentherm
Gentherm (NASDAQ:THRM) is a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests and other components), battery thermal management systems, cable systems and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 11,000 employees in facilities in the United States, Germany, China, Hungary, Japan, Korea, North Macedonia, Malta, Mexico, United Kingdom, Ukraine, and Vietnam. For more information, go to www.gentherm.com.
Forward-Looking Statements
Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent Gentherm Incorporated's goals, beliefs, plans and expectations about its prospects for the future and other future events. The forward-looking statements included in this release are made as of the date hereof or as of the date specified herein and are based on management's reasonable expectations and beliefs. Such statements are subject to a number of important assumptions, risks, uncertainties and other factors that may cause actual results or performance to differ materially from that described in or indicated by the forward-looking statements, including:
- the COVID-19 pandemic and its direct and indirect adverse impacts on the automobile and medical industries, global supply chain and global economy, which had, and may continue to have, an adverse effect on, among other things, the Company’s results of operations, financial condition, cash flows, liquidity, borrowing availability under the Company’s revolving credit facility, business operations, and stock price;
- the loss of any key suppliers, or any material delays in the supply chain of the Company or the OEMs and Tier 1s supplied by the Company, including resulting from a shortage of key components (such as the significant supply disruptions currently faced by the automotive industry, including relating to semiconductors);
- reductions in the Company’s manufacturing capacity and productivity due to adverse impacts of shifts and turnover in the labor market;
- the Company’s failure to be in compliance with covenants under its debt agreements, which could result in the amounts outstanding thereunder being accelerated and becoming immediately due and payable;
- the Company’s ability to obtain additional financing by accessing the capital markets, which may not be available on acceptable terms or at all;
- the macroeconomic environment, including its impact on the automotive industry, which is cyclical;
- any significant declines or slower growth than anticipated in light vehicle production, and in particular in markets for electric vehicles;
- market acceptance of the Company’s existing or new products, and new or improved competing products developed by competitors with greater resources;
- shifting customer preferences, including due to the evolving use of automobiles and technology;
- the Company’s ability to project future sales volumes, based on which the Company manages its business;
- reductions in new business awards, which were limited in 2020, and could be limited in the future, due to COVID-19, global supply chain challenges and related uncertainties;
- the Company’s ability to convert new business awards into product revenues;
- managing the Company’s growth effectively and to integrate successfully any recent business ventures, acquisitions, and strategic investments and alliances into the Company’s business;
- the loss or insolvency of any of the Company’s key customers;
- the impact of price downs in the ordinary course, or additional increased pricing pressures from the Company’s customers;
- the feasibility of Company’s development of new products on a timely, cost effective basis, or at all;
- security breaches and other disruptions to the Company’s IT systems;
- work stoppages impacting the Company, its suppliers or customers;
- changes in free trade agreements or the implementation of additional tariffs, and the Company’s ability to pass-through tariff costs;
- unfavorable changes to currency exchange rates;
- the Company’s ability to protect its intellectual property in certain jurisdictions;
- the Company’s ability to effectively implement ongoing restructuring and other cost-savings measures or realize the full amount of estimated savings; and
- compliance with, and increased costs related to, domestic and international regulations.
The foregoing risks should be read in conjunction with the Company's filings with the Securities and Exchange Commission (the “SEC”), including “Risk Factors”, in its most recent Annual Report on Form 10-K and subsequent SEC filings, for a discussion of these and other risks and uncertainties. In addition, the business outlook discussed in this release does not include the potential impact of any business combinations, acquisitions, divestitures, strategic investments and other significant transactions that may be completed after the date hereof, each of which may present material risks to the Company’s future business and financial results.
Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
GENTHERM INCORPORATED
CONSOLIDATED CONDENSED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
Product revenues | $ | 243,384 | $ | 259,540 | $ | 797,924 | $ | 624,214 | ||||||||
Cost of sales | 173,997 | 176,935 | 561,655 | 448,807 | ||||||||||||
Gross margin | 69,387 | 82,605 | 236,269 | 175,407 | ||||||||||||
Operating expenses: | ||||||||||||||||
Net research and development expenses | 20,590 | 18,070 | 56,420 | 51,171 | ||||||||||||
Selling, general and administrative expenses | 27,344 | 25,745 | 83,093 | 73,474 | ||||||||||||
Restructuring expenses | 749 | 284 | 3,631 | 3,452 | ||||||||||||
Total operating expenses | 48,683 | 44,099 | 143,144 | 128,097 | ||||||||||||
Operating income | 20,704 | 38,506 | 93,125 | 47,310 | ||||||||||||
Interest expense, net | (515 | ) | (1,259 | ) | (2,184 | ) | (3,368 | ) | ||||||||
Foreign currency gain (loss) | 133 | (2,883 | ) | 391 | (5,562 | ) | ||||||||||
Other income (loss) | 10 | (615 | ) | 13 | 2,531 | |||||||||||
Earnings before income tax | 20,332 | 33,749 | 91,345 | 40,911 | ||||||||||||
Income tax expense | 4,646 | 9,603 | 17,959 | 15,214 | ||||||||||||
Net income | $ | 15,686 | $ | 24,146 | $ | 73,386 | $ | 25,697 | ||||||||
Basic earnings per share | $ | 0.47 | $ | 0.74 | $ | 2.22 | $ | 0.79 | ||||||||
Diluted earnings per share | $ | 0.47 | $ | 0.73 | $ | 2.19 | $ | 0.78 | ||||||||
Weighted average number of shares – basic | 33,178 | 32,624 | 33,075 | 32,631 | ||||||||||||
Weighted average number of shares – diluted | 33,609 | 32,958 | 33,489 | 32,924 | ||||||||||||
GENTHERM INCORPORATED
REVENUE BY PRODUCT CATEGORY AND RECONCILIATION OF FOREIGN CURRENCY TRANSLATION IMPACT
(In thousands)
(Unaudited)
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||
2021 | 2020 | % Change | 2021 | 2020 | % Change | |||||||||||||||
Climate Control Seat (CCS®) | $ | 89,991 | $ | 97,058 | (7.3 | )% | $ | 297,393 | $ | 229,465 | 29.6 | % | ||||||||
Seat Heaters | 61,516 | 73,471 | (16.3 | )% | 208,101 | 171,345 | 21.5 | % | ||||||||||||
Steering Wheel Heaters | 24,578 | 22,506 | 9.2 | % | 80,139 | 49,721 | 61.2 | % | ||||||||||||
Automotive Cables | 19,465 | 18,917 | 2.9 | % | 66,686 | 50,890 | 31.0 | % | ||||||||||||
Battery Performance Solutions (BPS) | 16,928 | 15,956 | 6.1 | % | 52,265 | 33,818 | 54.5 | % | ||||||||||||
Electronics | 11,567 | 14,463 | (20.0 | )% | 41,324 | 38,327 | 7.8 | % | ||||||||||||
Other Automotive | 8,983 | 7,393 | 21.5 | % | 21,595 | 17,056 | 26.6 | % | ||||||||||||
Subtotal Automotive segment | 233,028 | 249,764 | (6.7 | )% | 767,503 | 590,622 | 29.9 | % | ||||||||||||
Medical segment | 10,356 | 9,776 | 5.9 | % | 30,421 | 33,592 | (9.4 | )% | ||||||||||||
Total Company | $ | 243,384 | $ | 259,540 | — | $ | 797,924 | $ | 624,214 | — | ||||||||||
Foreign currency translation impact | 2,832 | — | 24,824 | — | ||||||||||||||||
Total Company, excluding foreign currency translation impact | $ | 240,552 | $ | 259,540 | (7.3 | )% | $ | 773,100 | $ | 624,214 | 23.9 | % | ||||||||
GENTHERM INCORPORATED
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA
(In thousands)
(Unaudited)
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
Net income | $ | 15,686 | $ | 24,146 | $ | 73,386 | $ | 25,697 | ||||||||
Add back: | ||||||||||||||||
Depreciation and amortization | 9,859 | 10,129 | 29,182 | 30,129 | ||||||||||||
Income tax expense | 4,646 | 9,603 | 17,959 | 15,214 | ||||||||||||
Interest expense | 515 | 1,259 | 2,184 | 3,368 | ||||||||||||
Adjustments: | ||||||||||||||||
Restructuring expense | 749 | 284 | 3,631 | 3,452 | ||||||||||||
Unrealized currency (gain) loss | (1,039 | ) | 4,117 | (1,345 | ) | 6,491 | ||||||||||
Gain on sale of patents | — | — | — | (1,978 | ) | |||||||||||
Acquisition and divestiture expenses | 65 | 608 | 1,023 | 608 | ||||||||||||
Adjusted EBITDA | $ | 30,481 | $ | 50,146 | $ | 126,020 | $ | 82,981 | ||||||||
Product revenues | $ | 243,384 | $ | 259,540 | $ | 797,924 | $ | 624,214 | ||||||||
Adjusted EBITDA % | 12.5 | % | 19.3 | % | 15.8 | % | 13.3 | % |
Use of Non-GAAP Financial Measures
In addition to the results reported in accordance with GAAP throughout this release, the Company has provided here or elsewhere information regarding adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”), Adjusted EBITDA margin, adjusted earnings per share (“Adjusted earnings per share” or “Adjusted EPS”), free cash flow, Net Debt and Revenue excluding the impact of foreign currency translation, each a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, and other gains and losses not reflective of the Company’s ongoing operations and related tax effects including transaction expenses, debt retirement expenses, impairment of assets held for sale, gain or loss on sale of business, restructuring expense, unrealized currency gain or loss and unrealized revaluation of derivatives. The Company defines Adjusted EBITDA margin as Adjusted EBITDA divided by product revenues. The Company defines Adjusted EPS as earnings adjusted by gains and losses not reflective of the Company’s ongoing operations and related tax effects including transaction expenses, debt retirement expenses, impairment of assets held for sale, gain or loss on sale of business, restructuring expense, unrealized currency gain or loss and unrealized revaluation of derivatives. The Company defines Free Cash Flow as Net cash provided by operating activities less Purchases of property and equipment. The Company defines Net Debt as the principal amount of all Consolidated Funded Indebtedness (as defined in the Credit Agreement) less cash and cash equivalents. The Company defines Revenue excluding the impact of foreign currency translation as revenue, less the estimated effects of foreign currency exchange on revenue by translating actual revenue using the prior period foreign currency exchange rates.
The Company’s reconciliations are included in this release or can be found in the supplemental materials furnished as Exhibit 99.2 to the Company’s Form 8-K dated October 28, 2021.
In evaluating its business, the Company considers and uses Free Cash Flow and Net Debt as supplemental measures of its liquidity and the other non-GAAP financial measures as supplemental measures of its operating performance. Management provides such non-GAAP financial measures so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company's performance on a period-over-period basis by excluding matters not indicative of the Company’s ongoing operating or liquidity results. In evaluating our non-GAAP financial measures, you should be aware that in the future we may incur revenues, expenses, and cash and non-cash obligations that are the same as or similar to some of the adjustments in our presentation of non-GAAP financial measures. Our presentation of non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. There also can be no assurance that we will not modify the presentation of our non-GAAP financial measures in the future, and any such modification may be material. Other companies in our industry may define and calculate these non-GAAP financial measures differently than we do and those calculations may not be comparable to our metrics. These non-GAAP measures have limitations as analytical tools, and when assessing the Company's operating performance or liquidity, investors should not consider these non-GAAP measures in isolation, or as a substitute for net income, revenue or other consolidated income statement or cash flow statement data prepared in accordance with GAAP.
Non-GAAP measures referenced in this release and other public communications may include estimates of future Adjusted EBITDA, Adjusted EBITDA margin and Adjusted EPS. Such forward-looking non-GAAP measures may differ significantly from the corresponding GAAP measures, due to depreciation and amortization, tax expense, and/or interest expense, some or all of which management has not quantified for the future periods.
GENTHERM INCORPORATED
ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE
(In thousands, except per share data)
(Unaudited)
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
Net income | $ | 15,686 | $ | 24,146 | $ | 73,386 | $ | 25,697 | ||||||||
Non-cash purchase accounting impact | 2,141 | 2,259 | 6,241 | 6,543 | ||||||||||||
Restructuring expenses | 749 | 284 | 3,631 | 3,452 | ||||||||||||
Unrealized currency (gain) loss | (1,039 | ) | 4,117 | (1,345 | ) | 6,491 | ||||||||||
Gain on sale of patents | — | — | — | (1,978 | ) | |||||||||||
Acquisition and divestiture expenses | 65 | 608 | 1,023 | 608 | ||||||||||||
Tax effect of above | (566 | ) | (1,435 | ) | (2,557 | ) | (3,764 | ) | ||||||||
Adjusted net income | $ | 17,036 | $ | 29,979 | $ | 80,379 | $ | 37,049 | ||||||||
Weighted average shares outstanding: | ||||||||||||||||
Basic | 33,178 | 32,624 | 33,075 | 32,631 | ||||||||||||
Diluted | 33,609 | 32,958 | 33,489 | 32,924 | ||||||||||||
Earnings per share, as reported: | ||||||||||||||||
Basic | $ | 0.47 | $ | 0.74 | $ | 2.22 | $ | 0.79 | ||||||||
Diluted | $ | 0.47 | $ | 0.73 | $ | 2.19 | $ | 0.78 | ||||||||
Adjusted earnings (loss) per share: | ||||||||||||||||
Basic | $ | 0.51 | $ | 0.92 | $ | 2.43 | $ | 1.14 | ||||||||
Diluted | $ | 0.51 | $ | 0.91 | $ | 2.40 | $ | 1.13 |
GENTHERM INCORPORATED
CONSOLIDATED CONDENSED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)
September 30, 2021 | December 31, 2020 | |||||||
ASSETS | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | 195,086 | $ | 268,345 | ||||
Accounts receivable, net | 182,324 | 211,672 | ||||||
Inventory: | ||||||||
Raw materials | 89,017 | 68,362 | ||||||
Work in process | 12,460 | 8,247 | ||||||
Finished goods | 52,819 | 45,792 | ||||||
Inventory, net | 154,296 | 122,401 | ||||||
Other current assets | 41,997 | 41,188 | ||||||
Total current assets | 573,703 | 643,606 | ||||||
Property and equipment, net | 155,788 | 152,581 | ||||||
Goodwill | 66,769 | 68,024 | ||||||
Other intangible assets, net | 39,140 | 46,421 | ||||||
Operating lease right-of-use assets | 24,718 | 30,642 | ||||||
Deferred income tax assets | 67,307 | 73,912 | ||||||
Other non-current assets | 16,553 | 7,653 | ||||||
Total assets | $ | 943,978 | $ | 1,022,839 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current Liabilities: | ||||||||
Accounts payable | $ | 124,000 | $ | 116,043 | ||||
Current lease liabilities | 5,948 | 6,032 | ||||||
Current maturities of long-term debt | 2,500 | 2,500 | ||||||
Other current liabilities | 82,905 | 81,409 | ||||||
Total current liabilities | 215,353 | 205,984 | ||||||
Long-term debt, less current maturities | 37,500 | 189,934 | ||||||
Non-current lease liabilities | 20,313 | 24,233 | ||||||
Pension benefit obligation | 7,531 | 8,163 | ||||||
Other non-current liabilities | 7,801 | 8,194 | ||||||
Total liabilities | $ | 288,498 | $ | 436,508 | ||||
Shareholders’ equity: | ||||||||
Common Stock: | ||||||||
No par value; 55,000,000 shares authorized 33,224,779 and 32,921,341 issued and outstanding at September 30, 2021 and December 31, 2020, respectively | 135,449 | 121,073 | ||||||
Paid-in capital | 5,980 | 7,458 | ||||||
Accumulated other comprehensive loss | (32,117 | ) | (14,982 | ) | ||||
Accumulated earnings | 546,168 | 472,782 | ||||||
Total shareholders’ equity | 655,480 | 586,331 | ||||||
Total liabilities and shareholders’ equity | $ | 943,978 | $ | 1,022,839 | ||||
GENTHERM INCORPORATED
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Nine Months Ended September 30, | ||||||||
2021 | 2020 | |||||||
Operating Activities: | ||||||||
Net income | $ | 73,386 | $ | 25,697 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 29,430 | 30,777 | ||||||
Deferred income taxes | 3,867 | 3,583 | ||||||
Non-cash stock based compensation | 9,422 | 6,569 | ||||||
Change in defined benefit pension plans | (650 | ) | (433 | ) | ||||
Loss on disposition of property and equipment | 638 | 562 | ||||||
Gain on sale of patents | — | (1,978 | ) | |||||
Changes in assets and liabilities: | ||||||||
Accounts receivable, net | 26,162 | (33,250 | ) | |||||
Inventory | (34,019 | ) | 4,645 | |||||
Other assets | 10 | (57 | ) | |||||
Accounts payable | 9,231 | 24,272 | ||||||
Other liabilities | (371 | ) | 12,914 | |||||
Net cash provided by operating activities | 117,106 | 73,301 | ||||||
Investing Activities: | ||||||||
Purchases of property and equipment | (29,585 | ) | (11,613 | ) | ||||
Acquisition of intangible assets | — | (3,141 | ) | |||||
Proceeds from the sale of patents and property and equipment | 11 | 1,068 | ||||||
Acquisition of business | (2,827 | ) | — | |||||
Cost of technology investments | (7,557 | ) | — | |||||
Net cash used in investing activities | (39,958 | ) | (13,686 | ) | ||||
Financing Activities: | ||||||||
Borrowing of debt | — | 201,193 | ||||||
Repayments of debt | (151,993 | ) | (87,688 | ) | ||||
Cash paid for the repurchase of Common Stock | — | (9,092 | ) | |||||
Proceeds from the exercise of Common Stock options | 7,467 | 6,828 | ||||||
Cash paid for the cancellation of restricted stock | (3,991 | ) | (811 | ) | ||||
Acquisition contingent consideration payment | (69 | ) | (618 | ) | ||||
Net cash (used in) provided by financing activities | (148,586 | ) | 109,812 | |||||
Foreign currency effect | (1,821 | ) | 6,664 | |||||
Net (decrease) increase in cash, cash equivalents and restricted cash | (73,259 | ) | 176,091 | |||||
Cash, cash equivalents and restricted cash at beginning of period | 268,345 | 52,948 | ||||||
Cash, cash equivalents and restricted cash at end of period | $ | 195,086 | $ | 229,039 | ||||
Supplemental disclosure of cash flow information: | ||||||||
Cash paid (refund) for taxes | $ | 12,348 | $ | (252 | ) | |||
Cash paid for interest | $ | 1,823 | $ | 3,006 | ||||
FAQ
What are Gentherm's third quarter 2021 revenues?
How much did Gentherm secure in automotive awards in Q3 2021?
What is Gentherm's updated full-year revenue guidance for 2021?
How did Gentherm's earnings per share change in Q3 2021?